Your browser doesn't support javascript.
loading
Anti-thymocyte globulins capable of binding to T and B cells reduce graft-vs-host disease without increasing relapse.
Hoegh-Petersen, M; Amin, M A; Liu, Y; Ugarte-Torres, A; Williamson, T S; Podgorny, P J; Russell, J A; Grigg, A; Ritchie, D; Storek, J.
Affiliation
  • Hoegh-Petersen M; Department of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 1N4. mhoeghpe@ucalgary.ca
Bone Marrow Transplant ; 48(1): 105-14, 2013 Jan.
Article in En | MEDLINE | ID: mdl-22659684
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: B-Lymphocytes / T-Lymphocytes / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease / Immunosuppressive Agents / Antilymphocyte Serum Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: Bone Marrow Transplant Year: 2013 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: B-Lymphocytes / T-Lymphocytes / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease / Immunosuppressive Agents / Antilymphocyte Serum Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: Bone Marrow Transplant Year: 2013 Document type: Article